MARKER THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MARKER THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was $3.66K, a 28.78% decline year-over-year.
- MARKER THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $1.70K, a 97.99% decline year-over-year.
- MARKER THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $7.70K, a 946.74% increase year-over-year.
- MARKER THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $49.10K.
- MARKER THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $62.16K, a 31.30% decline from fiscal 2023.
- MARKER THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $90.48K.
- MARKER THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $3.09K.
- MARKER THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $57.74K, a 218.59% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $3.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $62.16K 10-K · filed 2026-03-18 |
| 2024-09-30 | $1.70K 10-Q · filed 2025-11-13 | $63.64K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $7.70K 10-Q · filed 2025-08-14 | $146.54K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $49.10K 10-Q · filed 2025-05-15 | $139.57K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $5.14K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $90.48K 10-K · filed 2025-03-31 |
| 2023-09-30 | $84.60K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $736.00 10-Q · filed 2024-08-14 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.09K 10-K · filed 2023-03-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2021-06-30 | $3.09K 10-Q · filed 2022-08-11 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $57.74K 10-K · filed 2021-03-09 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $57.74K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $57.74K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $57.74K 10-Q · filed 2020-05-11 | $57.74K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $18.13K 10-K · filed 2020-03-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | |
| 2018-03-31 | $18.13K 10-Q · filed 2019-05-10 | |
| 2016-12-31 | $18.13K 10-K · filed 2018-03-23 | |
| 2004-12-31 | $205.09K 10-K · filed 2012-04-16 | |
| 2003-12-31 | $1.42M 10-K · filed 2012-04-16 | |
| 2002-12-31 | $51.00K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |